Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
J Virol. 2020 Aug 31;94(18). doi: 10.1128/JVI.01053-20.
Unlike RNA viruses, most DNA viruses replicate their genomes with high-fidelity polymerases that rarely make base substitution errors. Nevertheless, experimental evolution studies have revealed rapid acquisition of adaptive mutations during serial passage of attenuated vaccinia virus (VACV). One way in which adaptation can occur is by an accordion mechanism in which the gene copy number increases followed by base substitutions and, finally, contraction of the gene copy number. Here, we show rapid acquisition of multiple adaptive mutations mediated by a gene-inactivating frameshift mechanism during passage of an attenuated VACV. Attenuation had been achieved by exchanging the VACV A8R intermediate transcription factor gene with the myxoma virus ortholog. A total of seven mutations in six different genes occurred in three parallel passages of the attenuated virus. The most frequent mutations were single-nucleotide insertions or deletions within runs of five to seven As or Ts, although a deletion of 11 nucleotides also occurred, leading to frameshifts and premature stop codons. During 10 passage rounds, the attenuated VACV was replaced by the mutant viruses. At the end of the experiment, virtually all remaining viruses had one fixed mutation and one or more additional mutations. Although nucleotide substitutions in the transcription apparatus accounted for two low-frequency mutations, frameshifts in genes encoding protein components of the mature virion, namely, A26L, G6R, and A14.5L, achieved 74% to 98% fixation. The adaptive role of the mutations was confirmed by making recombinant VACV with A26L or G6R or both deleted, which increased virus replication levels and decreased particle/PFU ratios. Gene inactivation is considered to be an important driver of orthopoxvirus evolution. Whereas cowpox virus contains intact orthologs of genes present in each orthopoxvirus species, numerous genes are inactivated in all other members of the genus. Inactivation of additional genes can occur upon extensive passaging of orthopoxviruses in cell culture leading to attenuation , a strategy for making vaccines. Whether inactivation of multiple viral genes enhances replication in the host cells or has a neutral effect is unknown in most cases. Using an experimental evolution protocol involving serial passages of an attenuated vaccinia virus, rapid acquisition of inactivating frameshift mutations occurred. After only 10 passage rounds, the starting attenuated vaccinia virus was displaced by viruses with one fixed mutation and one or more additional mutations. The high frequency of multiple inactivating mutations during experimental evolution simulates their acquisition during normal evolution and extensive virus passaging to make vaccine strains.
与 RNA 病毒不同,大多数 DNA 病毒利用具有高保真度聚合酶的机制来复制其基因组,这些聚合酶很少发生碱基替换错误。然而,实验进化研究表明,在减毒牛痘病毒(VACV)的连续传代过程中,适应性突变会迅速获得。适应的一种方式是通过基因拷贝数增加,然后是碱基替换,最后是基因拷贝数收缩的手风琴机制。在这里,我们展示了在减毒 VACV 的传代过程中,通过基因失活框移突变机制迅速获得多种适应性突变。通过用兔粘液瘤病毒的同源物交换 VACV A8R 中间转录因子基因来实现衰减。在三个平行的衰减病毒传代中,总共在六个不同基因中发生了七个突变。最常见的突变是在五个到七个 As 或 Ts 的连续序列中发生单个核苷酸的插入或缺失,尽管也发生了 11 个核苷酸的缺失,导致框移和过早的终止密码子。在 10 个传代轮次中,减毒 VACV 被突变病毒取代。在实验结束时,几乎所有剩余的病毒都有一个固定的突变和一个或多个额外的突变。尽管转录装置中的核苷酸替换导致了两个低频突变,但成熟病毒粒子蛋白成分编码基因中的框移,即 A26L、G6R 和 A14.5L,达到了 74%至 98%的固定率。通过删除 A26L 或 G6R 或两者的重组 VACV 证实了突变的适应性作用,这增加了病毒复制水平并降低了粒子/ PFU 比。基因失活被认为是正痘病毒进化的重要驱动因素。虽然牛痘病毒包含每个正痘病毒物种中存在的完整的同源基因,但在该属的所有其他成员中,许多基因都失活。在细胞培养中对正痘病毒进行广泛传代会导致减毒,这是制造疫苗的一种策略,从而导致其他基因的失活。在大多数情况下,失活多个病毒基因是否增强了宿主细胞中的复制或具有中性效应尚不清楚。使用涉及减毒牛痘病毒连续传代的实验进化方案,迅速获得了失活框移突变。仅在 10 个传代轮次后,起始的减毒牛痘病毒就被具有一个固定突变和一个或多个额外突变的病毒所取代。在实验进化过程中,失活框移突变的高频发生模拟了它们在正常进化和广泛病毒传代过程中获得的情况,以产生疫苗株。